Option chain shows key data for Aditxt's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Aditxt.

Aditxt (NASDAQ:ADTX) Stock, Option Chain

Aditxt

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.

oil rig

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

ADTX

EGRX

JOBY

Crude Oil Edges Higher; ConAgra Posts Downbeat Earnings

Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Intraday Update

GLDD

Dow Gains 100 Points; Joby Aviation Shares Spike Higher

Wall Street

AREB

KXIN

US Stocks Edge Lower; Private Employment Beats Expectations

Aditxt Inc

The earnings results for TDK (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TTDKY#OTC">TTDKY</a>) for Q3 were made public on Friday, January 31, 2025 at 03:00 AM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
TDK beat estimated earnings by 6.0%, reporting an EPS of $0.19 versus an estimate of $0.18.
Revenue was up $29.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company beat on EPS by $0.17 in the previous quarter, leading to a 4.0% increase share price change the next day.
Here's a look at TDK's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.20</td>
<td>0.10</td>
<td>0.04</td>
<td>0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.37</td>
<td>0.22</td>
<td>0.02</td>
<td>0.23</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>3.98B</td>
<td>3.19B</td>
<td>3.23B</td>
<td>3.84B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>3.83B</td>
<td>3.33B</td>
<td>3.27B</td>
<td>3.79B</td>
</tr>
</tbody>
</table>

To track all earnings releases for TDK <a href="https://www.benzinga.com/quote/TTDKY/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TTDKY

Recap: TDK Q3 Earnings

Toyota Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) retained its position as the world&#8217;s best-selling automaker in 2024 after reporting 10.8 million sales, marking a dip of 4% from a year ago. 
What Happened: The dip in sales, the company said, was spurred by a near 20% fall in sales within its home ground of Japan. Domestic vehicle sales, it said, were affected by certification issues and suspension of production of the Prius. 
The sales numbers include those of the company&#8217;s Lexus brand as well as its subsidiaries Daihatsu and Hino. Daihatsu reported sales of 536,588 units worldwide in 2024 while Hino reported sales of 125,556 units. 
German automaker Volkswagen Group, in comparison, sold only about 9 million vehicles last year.
Toyota Trails Behind Tesla In EV Sales: Despite retaining its position as the top-selling automaker globally for five straight years, Toyota&#8217;s electrified vehicle sales amounted to just 4.5 million vehicles in 2024. Electrified vehicles refer collectively to <a href="https://www.benzinga.com/tech/25/01/42809131/toyota-overtakes-ford-gm-in-ev-sales-in-us-thanks-to-its-hybrid-vehicle-lineup">hybrid, plug-hybrid</a>, battery-powered, mild hybrid, and fuel-cell electric vehicles. 
The company sold only 139,892 battery electric vehicles or pure electric vehicles throughout the year, lower than American EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) or Chinese EV maker BYD Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>).
Tesla delivered nearly<a href="https://www.benzinga.com/25/01/42780142/chinese-player-byd-overtakes-tesla-yet-again-as-worlds-biggest-ev-seller-in-q4"> 1.79 million BEVs in 2024</a> while BYD delivered 1.76 million pure electric vehicles. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43375903/tesla-researcher-estimates-drop-in-ev-deliveries-for-2025-despite-promise-of-new-models" target="_blank" rel="noreferrer noopener">Tesla Researcher Predicts Drop In Deliveries For Elon Musk's EV Giant In 2025 Despite New Model Launches</a></li>
</ul>
Photo by josefkubes on Shutterstock

Tech

BYDDF

TSLA

Toyota Retains Top-Selling Automaker Position While Continuing to Trail Tesla, BYD In EV Sales

The European Commission (EC), which has the authority to approve medicines for the European Union (EU), will now review the CHMP recommendation.

Bristol Myers Squibb Gets Positive CHMP Opinion For CAR T Cell Therapy Breyanzi For Relapsed Or Refractory Follicular Lymphoma

The earnings results for TDK (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TTDKY#OTC">TTDKY</a>) for Q3 were made public on Friday, January 31, 2025 at 03:00 AM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
TDK beat estimated earnings by 6.0%, reporting an EPS of $0.19 versus an estimate of $0.18.
Revenue was up $29.00 million from the same period last year.
<h3>Historical Earnings Summary</h3>
Last quarter the company beat on EPS by $0.17 which was followed by a 4.0% increase in the share price the next day.
Here's a look at TDK's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.20</td>
<td>0.10</td>
<td>0.04</td>
<td>0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.37</td>
<td>0.22</td>
<td>0.02</td>
<td>0.23</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>3.98B</td>
<td>3.19B</td>
<td>3.23B</td>
<td>3.84B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>3.83B</td>
<td>3.33B</td>
<td>3.27B</td>
<td>3.79B</td>
</tr>
</tbody>
</table>

To track all earnings releases for TDK <a href="https://www.benzinga.com/quote/TTDKY/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: TDK Q3

The&nbsp;&nbsp;&nbsp;&nbsp;Company&nbsp;&nbsp;&nbsp;&nbsp;declared&nbsp;&nbsp;&nbsp;&nbsp;a&nbsp;&nbsp;&nbsp;&nbsp;regular&nbsp;&nbsp;&nbsp;&nbsp;quarterly&nbsp;&nbsp;&nbsp;&nbsp;dividend&nbsp;&nbsp;&nbsp;&nbsp;of&nbsp;&nbsp;&nbsp;&nbsp;$0.55&nbsp;&nbsp;&nbsp;&nbsp;per&nbsp;&nbsp;&nbsp;&nbsp;share,&nbsp;&nbsp;&nbsp;&nbsp;an&nbsp;&nbsp;&nbsp;&nbsp;increase&nbsp;&nbsp;&nbsp;&nbsp;of&nbsp;&nbsp;&nbsp;&nbsp;7.8&nbsp;&nbsp;&nbsp;&nbsp;percent,&nbsp;&nbsp;&nbsp;&nbsp;which&nbsp;&nbsp;&nbsp;&nbsp;is&nbsp;&nbsp;&nbsp;&nbsp;payable&nbsp;&nbsp;&nbsp;&nbsp;on&nbsp;&nbsp;&nbsp;&nbsp;March&nbsp;&nbsp;&nbsp;&nbsp;4,&nbsp;&nbsp;&nbsp;&nbsp;2025&nbsp;&nbsp;&nbsp;&nbsp;to&nbsp;&nbsp;&nbsp;&nbsp;stockholders&nbsp;&nbsp;&nbsp;&nbsp;of&nbsp;&nbsp;&nbsp;&nbsp;record&nbsp;&nbsp;&nbsp;&nbsp;on&nbsp;&nbsp;&nbsp;&nbsp;February&nbsp;&nbsp;&nbsp;&nbsp;14,&nbsp;&nbsp;&nbsp;&nbsp;2025.&nbsp;&nbsp;&nbsp;&nbsp;

Dividends

Booz Allen Hamilton Declared A QUarterly Dividend Per Share Of $0.55, Up By 7.8%

Brookfield Bus Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBU#NYSE">BBU</a>) reported $7.427 billion in sales this quarter. This is a 44.60 percent decrease over sales of $13.405 billion the same period last year.

Brookfield Bus Partners Q4 Sales $7.427B Down From $13.405B YoY

Needham analyst Ryan Koontz maintains Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) with a Buy and raises the price target from $45 to $53.

Price Target

Analyst Ratings

CALX

Needham Maintains Buy on Calix, Raises Price Target to $53

Needham analyst Quinn Bolton reiterates Allegro Microsystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) with a Buy and maintains $30 price target.

Reiteration

ALGM

Needham Reiterates Buy on Allegro Microsystems, Maintains $30 Price Target

Earnings Beats

Booz Allen Hamilton Q3 2025 Adj. EPS $1.55 Beats $1.51 Estimate, Sales $2.917B Beat $2.864B Estimate

Merck Says Committee For Medicinal Products For Human Use Of The European Medicines Agency Recommended The Approval Of CAPVAXIVE For Active Immunization Of Invasive Disease And Pneumonia Caused By Streptococcus Pneumoniae

TDK (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TTDKY#OTC">TTDKY</a>) reported its Q3 earnings results on Friday, January 31, 2025 at 03:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
TDK beat estimated earnings by 6.0%, reporting an EPS of $0.19 versus an estimate of $0.18.
Revenue was up $29.00 million from the same period last year.
<h3>Overview of Past Earnings</h3>
Last quarter the company beat on EPS by $0.17 which was followed by a 4.0% increase in the share price the next day.
Here's a look at TDK's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.20</td>
<td>0.10</td>
<td>0.04</td>
<td>0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.37</td>
<td>0.22</td>
<td>0.02</td>
<td>0.23</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>3.98B</td>
<td>3.19B</td>
<td>3.23B</td>
<td>3.84B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>3.83B</td>
<td>3.33B</td>
<td>3.27B</td>
<td>3.79B</td>
</tr>
</tbody>
</table>

To track all earnings releases for TDK <a href="https://www.benzinga.com/quote/TTDKY/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TDK Q3 Earnings Assessment

Evercore ISI Group analyst James Kammert initiates coverage on NNN REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>) with a In-Line rating and announces Price Target of $42.

Initiation

Evercore ISI Group Initiates Coverage On NNN REIT with In-Line Rating, Announces Price Target of $42

Fujitsu (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FJTSY#OTC">FJTSY</a>) lowers FY2024 GAAP EPS guidance from $0.77 to $0.76. Lowers FY2024 sales outlook from $25.26 billion to $22.78 billion.

Guidance

FJTSY

Fujitsu Lowers FY2024 GAAP EPS Guidance from $0.77 to $0.76; Lowers FY2024 Sales Guidance from $25.26B to $22.78B

WIIM

Signing Day Sports shares are trading higher after the company announced it retains rights as the National Recruiting Partner to the U.S. Army Bowl through 2026 in new deal.

Fujitsu (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FJTSY#OTC">FJTSY</a>) lowers FY2024 Adj EPS guidance from $0.82 to $0.81. sees Adj sales of $22.784 billion.

Fujitsu Lowers FY2024 Adj EPS Guidance from $0.82 to $0.81; Sees Adj Sales $22.784B

B of A Securities analyst Jessica Reif Cohen downgrades Comcast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) from Buy to Neutral and lowers the price target from $50 to $38.

Downgrades

CMCSA

B of A Securities Downgrades Comcast to Neutral, Lowers Price Target to $38

Signing Day Sports Announced The Signing Of A New Sponsorship Agreement With The US Army Bowl  Through 2026, Extending Its Rights As "National Recruiting Partner"

Fujitsu (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FJTSY#OTC">FJTSY</a>) reported quarterly earnings of $0.04 per share. This is a 200 percent increase over losses of $(0.04) per share from the same period last year. The company reported $6.07 billion in sales this quarter. This is a 3.63 percent decrease over sales of $6.30 billion the same period last year.

Fujitsu Q3 EPS $0.04 Up From $(0.04) YoY, Sales $6.07B Down From $6.30B YoY

U.S. stock futures climbed on Friday, pointing to a third straight week of gains fueled by strong corporate earnings. Futures were higher for all four major indices.
The dollar index strengthened after Donald Trump announced Thursday that the U.S. will implement a 25% tariff on imports from Canada and Mexico, effective Saturday, Feb. 1. He also threatened the <a href="https://www.benzinga.com/government/regulations/25/01/43377987/after-imposing-tariffs-on-canada-donald-trump-threatens-100-levy-on-brics-for-move-against-dollar-how-will-us-manage-production-from-slippers-to-ships-asks-expert">BRICS nations</a> to impose 100% tariffs if they issue BRICS reserve currency.
Investors await the Personal Consumption Expenditure data for December, which will be released before the market opens.
The 10-year Treasury yield is currently at 4.53%, and the two-year yield is at 4.21%. The CME Group&#8217;s FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.htm">tool </a>indicates an 82% probability that the Federal Open Market Committee will maintain current interest rates in March 2025.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>0.78%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.45%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.34%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.01%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Friday, both the SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and the Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) were higher. SPY was up 0.42% at $607.59, and QQQ gained 0.80% to reach $527.22, based on <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Stocks rallied Thursday following mixed reactions to a wave of earnings reports and economic data.
This followed Wednesday&#8217;s down session after the Fed held rates steady. Investor sentiment fluctuated due to DeepSeek&#8217;s low-cost AI model launch and Big Tech earnings, this week.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) shares fell 0.74% despite beating first-quarter revenue and earnings estimates as iPhone sales slipped in 2024 to $69.14 billion, versus $69.7 billion last year. Revenue reached $124.3 billion as compared to $124.13 billion expected by Benzinga Pro, and adjusted earnings per share was $2.40 as compared to the expectation of $2.36 per share.
IBM Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) surged nearly 13% on artificial intelligence growth, Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) gained 1.6% on strong results, while Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) fell 6.2% despite exceeding expectations due to weaker cloud revenue.
On the economic front, Q4 GDP growth and jobless claims were slightly below forecasts, but overall economic indicators remain strong, with the Fed, on Wednesday, citing a robust labor market and &#8220;somewhat elevated&#8221; inflation.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.25%</td>
<td>19,681.75</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.53%</td>
<td>6,071.17</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.38%</td>
<td>44,882.13</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.07%</td>
<td>2,307.45</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
According to the analysts at BlackRock, strong corporate earnings have set the tone for the fourth-quarter season in swing.
&#8220;Even with higher-for-longer interest rates, we think U.S. stocks can keep outperforming this year. We stay overweight. Resilient economic growth is helping sectors beyond tech. That's partly driven by artificial intelligence (AI) spurring earnings beyond the initial winners during an economic transformation and policy change, we think. Yet we eye risks to risk appetite changing this year depending on earnings and policy.&#8221;
With interest rates in focus Ed Yardeni and Eric Wallerstein of Yradeni Research, said in their QuickTakes note that Fed Chair Jerome Powell&#8217;s basic message during his press conference was that the Fed is in no hurry to lower interest rates, but the Fed still intends to lower them over time.
Hence, they described it as a &#8220;dovish pause&#8221;.
Approaching the week from a technical perspective Jeff Buchbinder, the chief equity strategist at LPL Financial said that the S&amp;P 500 remains near record-high territory amid improving market breadth and momentum. &#8220;Technical damage within the heavy-weight tech sector has been minimal as buyers stepped up near support from the mid-January lows.&#8221;
Despite Monday's pullback, sector breadth is also holding up relatively well, with the majority of tech stocks trading above their 200-day moving average, Buchbinder added.
&#8220;However, technical damage has been more pronounced on a relative basis, as the tech sector vs. S&amp;P 500 ratio chart recently dropped to multi-month lows,&#8221; he said.
See Also:&nbsp;<a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Friday:
<ul>
<li>Fed Governor Michelle Bowman will be speaking at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Employment cost index data for Q4 will be released at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Also, the core and headline personal consumption expenditure, along with personal income and spending data will be announced at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>The Chicago Business Barometer (PMI) for January will be out by 9:45 a.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) was up 3.46% in the premarket on Friday after beating the fourth-quarter expectations on Tuesday, despite a slip in iPhone sales.</li>
</ul>
<ul>
<li>Colgate-Palmolive Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) was up 0.03% as Wall Street expects it to report earnings of 89 cents per share on revenue of $4.99 billion, before the opening bell.</li>
</ul>
<ul>
<li>Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) fell 0.86% ahead of its earnings to be released before the opening bell. Analysts expect it to report quarterly earnings of 23 cents per share on revenue of $32.24 billion.</li>
</ul>
<ul>
<li>Chevron Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) was down 0.17% as Wall Street expects it to report earnings of $2.11 per share on revenue of $48.41 billion, before the opening bell.</li>
</ul>
<ul>
<li>Other companies that are slated to report earnings today included Exxon Mobil Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) up 0.6%, Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) up 1.49%, Charter Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) up 2.09%, AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) up 0.99%, WW Grainger Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) up 1.05% and Charter Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) up 2.09%.</li>
</ul>
<ul>
<li>Nauticus Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) was up 46.15% after announcing a partnership to advance subsea autonomy solutions.</li>
</ul>
<ul>
<li>Cipher Mining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) was up 19.57% after the company announced a $50 million investment from Softbank.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 0.08% to hover around $72.67 per barrel.
The gold spot index was down by 0.08% to $2,791.94 per ounce. The Dollar Index was up 0.42% at 108.246 level.
Asian markets were higher on Friday except South Korea's Kospi index. Australia's ASX 200, Japan's Nikkei 225, South Korea's Kospi, Hong Kong's Hang Seng, and India's S&amp;P BSE Sensex rose. European markets were also higher in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43376448/elon-musks-x-money-to-see-about-600-million-active-monthly-users-via-visa-direct-integration">Elon Musk&#8217;s &#8216;X Money&#8217; To See About 600 Million Active Monthly Users Via Visa Direct Integration: &#8216;Excited To Partner,&#8217; Says CEO</a></li>
</ul>
Photo courtesy: Shutterstock

Analyst Color

Government

Market Summary

Regulations

Bonds

Broad U.S. Equity ETFs

Futures

Forex

Treasuries

Pre-Market Outlook

ETFs

General

AAPL

ABBV

CHTR

CIFR

KITT

MSFT

US Stock Futures Climb After Apple Beats Q4 Expectations: Expert Says Tech Stocks Hold Above Key Level Despite DeepSeek Impact

OneMain Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.15 by 0.87 percent. This is a 16.55 percent decrease over earnings of $1.39 per share from the same period last year. The company reported quarterly sales of $1.01 billion which missed the analyst consensus estimate of $1.04 billion by 3.27 percent. This is a 10.03 percent increase over sales of $917.00 million the same period last year.

Earnings Misses

OneMain Holdings Q4 Adj EPS $1.16 Beats $1.15 Estimate, Sales $1.01B Miss $1.04B Estimate

Small Cap

Press Releases

Evofem Secures Investor Support for Proposed Merger through Voting Agreements

Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem

Appili Therapeutics Announces Results of Special Meeting of Shareholders

Aditxt's Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders

Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025

Evofem Biosciences Announces Financial Results for the Third Quarter of 2024

Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.

Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials

Aditxt's Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform

APLIF

EVFM

TSX:APLI

HC Wainwright & Co.

Comments

Aditxt

Aditxt (ADTX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga